Immunotherapy is one of the most cutting-edge approaches in the treatment of cancer, receiving attention in many tumor sites throughout the body. Excitingly, radiation therapy can augment the efficacy of treatment, particularly high dose ablative approaches such as Stereotactic Radiosurgery (SRS). SRS has been shown to induce antigen specific anti-tumor immune responses and antigen-specific memory T-cells.